- Home
- OCFC vs NEO Comparison
OCFC vs NEO Comparison
Compare OCFC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFC
- NEO
- Stock Information
- Founded
- OCFC 1902
- NEO 2001
- Country
- OCFC United States
- NEO United States
- Employees
- OCFC N/A
- NEO N/A
- Industry
- OCFC Major Banks
- NEO Precision Instruments
- Sector
- OCFC Finance
- NEO Health Care
- Exchange
- OCFC Nasdaq
- NEO Nasdaq
- Market Cap
- OCFC 944.6M
- NEO 1.1B
- IPO Year
- OCFC 1996
- NEO 1999
- Fundamental
- Price
- OCFC $18.08
- NEO $9.11
- Analyst Decision
- OCFC Buy
- NEO Buy
- Analyst Count
- OCFC 4
- NEO 10
- Target Price
- OCFC $21.25
- NEO $12.56
- AVG Volume (30 Days)
- OCFC 286.3K
- NEO 2.9M
- Earning Date
- OCFC 10-22-2025
- NEO 10-28-2025
- Dividend Yield
- OCFC 4.42%
- NEO N/A
- EPS Growth
- OCFC N/A
- NEO N/A
- EPS
- OCFC 1.41
- NEO N/A
- Revenue
- OCFC $376,075,000.00
- NEO $689,189,000.00
- Revenue This Year
- OCFC N/A
- NEO $10.40
- Revenue Next Year
- OCFC $12.44
- NEO $10.11
- P/E Ratio
- OCFC $12.85
- NEO N/A
- Revenue Growth
- OCFC 0.00
- NEO 9.70
- 52 Week Low
- OCFC $14.29
- NEO $4.72
- 52 Week High
- OCFC $21.87
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- OCFC 54.39
- NEO 67.10
- Support Level
- OCFC $17.16
- NEO $7.56
- Resistance Level
- OCFC $18.36
- NEO $8.01
- Average True Range (ATR)
- OCFC 0.41
- NEO 0.38
- MACD
- OCFC -0.02
- NEO 0.06
- Stochastic Oscillator
- OCFC 65.00
- NEO 92.86
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.